A Clinical Study to Assess the Feasibility and Safety of Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer

Conditions: Non Metastatic Locally Recurrent Prostate Cancer Interventions: Device: Experimental: DaRT seeds Sponsors: Alpha Tau Medical LTD. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials